Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome

American Journal of Ophthalmology

Volumn 130, Issue 6, 2000, Pages 782-789

  Willemsen, Michél A A P ^a   Cruysberg, Johannes R M ^b   Rotteveel, Jan J ^a   Aandekerk, Albert L ^b   Van Domburg, Peter H M F ^c,d   Deutman, August F ^b  

^a Department of Pediatric Neurology ^*  (Netherlands)

^b Institute of Ophthalmology   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LAURENTIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; OXIDOREDUCTASE;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTIGMATISM; CLINICAL ARTICLE; DYSTROPHY; ENZYME DEFICIENCY; EVOKED VISUAL RESPONSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; MYOPIA; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA; RETINA MACULA LUTEA; SCHOOL CHILD; SJOEGREN LARSSON SYNDROME; VISUAL ACUITY;

ADOLESCENT; ADULT; ALDEHYDE OXIDOREDUCTASES; ASTIGMATISM; CHILD; CHILD, PRESCHOOL; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; INFANT; MACULAR DEGENERATION; MALE; METABOLISM, INBORN ERRORS; MYOPIA; PHOTOPHOBIA; SJOGREN-LARSSON SYNDROME; VISUAL ACUITY;

EID: 0034532555     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00576-6     Document Type: Article

References (41)

1. Oligophrenia in combination with congenital ichthyosis and spastic disorders. A clinical and genetic study
2. Sjogren-Larsson syndrome
3. Specific changes in the fundus typical for the Sjogren-Larsson syndrome. An ophthalmological study of 35 patients
4. Sjogren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts
5. Human liver fatty aldehyde dehydrogenase; microsomal localization, purification, and biochemical characterization
6. Involvement of microsomal fatty aldehyde dehydrogenase in the α-oxidation of phytanic acid
7. Sjogren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene
8. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjogren-Larsson syndrome
9. Unsuccessful dietary treatment of Sjogren-Larsson syndrome
10. Sjogren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity
11. Sjogren-Larsson syndrome. Clinical and MRI/MRS findings in FALDH deficient patients
12. A novel 4-bp deletion mutation in the FALDH gene segregating in a Turkish family with Sjogren-Larsson syndrome
13. The Sjogren-Larsson syndrome
14. Sjogren-Larsson syndrome; patient reports of two brothers
15. Sjogren-Larsson syndrome. Oligophrenia-ichthyosis-di/tetraplegia
16. Sjogren-Larsson syndrome; explaining the skin-brain connection
17. Syndrome de Sjogren-Larsson chez un nourisson
18. Lipofuscin and melanin content of the retinal pigment epithelium in a patient of Sjogren-Larsson syndrome
19. Neuropathological correlation in Sjogren-Larsson syndrome. Oligophrenia, ichthyosis and spasticity
20. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids; implications for Sjogren-Larsson syndrome
21. Polyunsaturated fatty acid metabolism in retinal and cerebral microvascular endothelial cells
22. Pathways for the uptake and conservation of docosahexaenoic acid in photoreceptors and synapses; biochemical and autoradiographic studies
23. Carotenoids in the human macula and whole retina
24. Lipids of human retina, retinal pigment epithelium, and Bruch's membrane/choroid; comparison of macular and peripheral regions
25. Fatty acid composition of the human macula and peripheral retina
26. Aldehyde dehydrogenases and their role in carcinogenesis
27. Defective inactivation of leukotriene B4 in patients with Sjogren-Larsson syndrome
28. Leukotrienes; biosynthesis, metabolism, and pathophysiologic significance
29. Arachidonic acid metabolism in human and bovine retina
30. Lipid mediators in the rat retina; light exposure and trauma elicit leukotriene B4 release in vitro
31. Polymorphonuclear leukocyte infiltration into the subretinal choroid and optic nerve in response to leukotrienes
32. Canthaxanthine retinopathy
33. Bietti's tapetoretinal degeneration with marginal corneal dystrophy
34. Metabolic pigmentary retinopathies; diagnosis and therapeutic attempts
35. Retinal abnormalities in Alport's syndrome
36. Long-term tamoxifen citrate use and potential ocular toxicity
37. Crystalline retinopathy
38. Flecked retinal disorders
39. Preterm birth in Sjogren-Larsson syndrome